{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:22:24Z","timestamp":1771395744003,"version":"3.50.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N41A640102"],"award-info":[{"award-number":["N41A640102"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.xphs.2025.104079","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T07:03:51Z","timestamp":1763881431000},"page":"104079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combinatorial therapeutic effect of liposomes in inhibiting prostate cancer aggressiveness and targeting cancer-associated fibroblast"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3573-2223","authenticated-orcid":false,"given":"Natsorn","family":"Watcharadulyarat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paweena","family":"Dana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prattana","family":"Tanyapanyachon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saksorn","family":"Klibaim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anukul","family":"Taweechaipaisankul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onuma","family":"Phoraksa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walailuk","family":"Chonniyom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wallaya","family":"Phongphaew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iyarath","family":"Putchong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nattika","family":"Saengkrit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2025.104079_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.xphs.2025.104079_bib0002","article-title":"Current trends in chemotherapy in the treatment of metastatic prostate cancer","author":"Zhao","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.xphs.2025.104079_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.627379","article-title":"Metastatic spread in prostate cancer patients influencing radiotherapy response","author":"Klusa","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.xphs.2025.104079_bib0004","doi-asserted-by":"crossref","DOI":"10.1007\/s00441-016-2467-x","article-title":"Fibroblast activation in cancer: when seed fertilizes soil","author":"Kuzet","year":"2016","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.xphs.2025.104079_bib0005","doi-asserted-by":"crossref","DOI":"10.1038\/35077241","article-title":"The microenvironment of the tumour - host interface","author":"Liotta","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.xphs.2025.104079_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071887","article-title":"The role of cancer-associated fibroblasts in prostate cancer tumorigenesis","author":"Bonollo","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.xphs.2025.104079_bib0007","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-22-1031","article-title":"Cancer-associated fibroblasts in inflammation and antitumor immunity","author":"Kennel","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.xphs.2025.104079_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","author":"Sahai","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.xphs.2025.104079_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.xphs.2025.104079_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xphs.2025.104079_bib0011","doi-asserted-by":"crossref","DOI":"10.1177\/1758834009359769","article-title":"Review: castration-resistant prostate cancer: new science and therapeutic prospects","author":"Bellmunt","year":"2010","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"10.1016\/j.xphs.2025.104079_bib0012","first-page":"13","article-title":"Docetaxel-related side effects and their management","author":"Baker","year":"2009","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.xphs.2025.104079_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjc.6602698","article-title":"Potential for improvement of docetaxel-based chemotherapy: a pharmacological review","author":"Engels","year":"2005","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.xphs.2025.104079_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2005.10.031","article-title":"A phase I clinical and pharmacokinetic study of Paclitaxel and Docetaxel given in combination in patients with solid tumours","volume":"42","author":"Izquierdo","year":"2006","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.xphs.2025.104079_bib0015","doi-asserted-by":"crossref","DOI":"10.1631\/jzus.B1200098","article-title":"Docetaxel-loaded liposomes: preparation, PH sensitivity, pharmacokinetics, and tissue distribution","volume":"13","author":"Zhang","year":"2012","journal-title":"J Zhejiang Univ Sci B"},{"issue":"1","key":"10.1016\/j.xphs.2025.104079_bib0016","article-title":"The therapeutic potential of resveratrol: a review of clinical trials","volume":"1","author":"Berman","year":"2017","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.xphs.2025.104079_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/jox11010002","article-title":"The effects of resveratrol on prostate cancer through targeting the tumor microenvironment","author":"Silk","year":"2021","journal-title":"J Xenobiotics"},{"key":"10.1016\/j.xphs.2025.104079_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.649395","article-title":"Resveratrol-based nanoformulations as an emerging therapeutic strategy for cancer","author":"Sharifi-Rad","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"7","key":"10.1016\/j.xphs.2025.104079_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158357","article-title":"Resveratrol-mediated repression and reversion of prostatic myofibroblast phenoconversion","volume":"11","author":"Gharaee-Kermani","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.xphs.2025.104079_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2018.05.031","article-title":"Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells","volume":"430","author":"Thongchot","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.xphs.2025.104079_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27165154","article-title":"Recent overview of Resveratrol\u2019s beneficial effects and its nano-delivery systems","author":"Bohara","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.xphs.2025.104079_bib0022","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122589","article-title":"The role of resveratrol in cancer therapy","author":"Ko","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xphs.2025.104079_bib0023","article-title":"Resveratrol-loaded nanomedicines for cancer applications","author":"Annaji","year":"2021","journal-title":"Cancer Rep"},{"issue":"1","key":"10.1016\/j.xphs.2025.104079_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/nano13010107","article-title":"Resveratrol loaded liposomes disrupt cancer associated fibroblast communications within the tumor microenvironment to inhibit colorectal cancer aggressiveness","volume":"13","author":"Dana","year":"2023","journal-title":"Nanomaterials"},{"key":"10.1016\/j.xphs.2025.104079_bib0025","doi-asserted-by":"crossref","DOI":"10.1186\/s12645-019-0055-y","article-title":"Nanomedicine review: clinical developments in liposomal applications","author":"Beltr\u00e1n-Gracia","year":"2019","journal-title":"Cancer Nanotechnol"},{"issue":"15","key":"10.1016\/j.xphs.2025.104079_bib0026","doi-asserted-by":"crossref","DOI":"10.2217\/nnm-2018-0510","article-title":"Dual PH-sensitive liposomes with low PH-triggered sheddable PEG for enhanced tumor-targeted drug delivery","volume":"14","author":"Kanamala","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.xphs.2025.104079_bib0027","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2840162","article-title":"Preparation of encapsulated resveratrol liposome thermosensitive gel and evaluation of its capability to repair sciatic nerve injury in rats","volume":"2020","author":"Yao","year":"2020","journal-title":"J Nanomater"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2025.104079_bib0028","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.xphs.2025.104079_bib0029","doi-asserted-by":"crossref","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.xphs.2025.104079_bib0030","doi-asserted-by":"crossref","DOI":"10.1084\/jem.115.3.453","article-title":"The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes","volume":"115","author":"BOYDEN","year":"1962","journal-title":"J Exp Med"},{"key":"10.1016\/j.xphs.2025.104079_bib0031","article-title":"Boyden Chamber Assay","volume":"294","author":"Chen","year":"2005","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.xphs.2025.104079_bib0032","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2025.104079_bib0033","article-title":"A comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials and patents","author":"Andra","year":"2022","journal-title":"BioNanoScience"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2025.104079_bib0034","article-title":"The size of liposomes: A factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs","volume":"40","author":"Nagayasu","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.xphs.2025.104079_bib0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-62501-1","article-title":"Optimization of docetaxel loading conditions in liposomes: proposing potential products for metastatic breast carcinoma chemotherapy","volume":"10","author":"Vakili-Ghartavol","year":"2020","journal-title":"Sci Rep"},{"issue":"24","key":"10.1016\/j.xphs.2025.104079_bib0036","doi-asserted-by":"crossref","DOI":"10.1007\/s00216-017-0527-z","article-title":"Potential: a case study of cationic, anionic, and neutral liposomes","volume":"409","author":"Smith","year":"2017","journal-title":"Anal Bioanal Chem"},{"issue":"872","key":"10.1016\/j.xphs.2025.104079_bib0037","article-title":"Lipid-based antimicrobial delivery-systems for the treatment of bacterial infections","volume":"7","author":"Wang","year":"2020","journal-title":"Front Chem"},{"issue":"3","key":"10.1016\/j.xphs.2025.104079_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-3495(99)77286-3","article-title":"Charge pairing of headgroups in phosphatidylcholine membranes: a molecular dynamics simulation study","volume":"76","author":"Pasenkiewicz-Gierula","year":"1999","journal-title":"Biophys J"},{"issue":"5","key":"10.1016\/j.xphs.2025.104079_bib0039","article-title":"Guidance to improve the scientific value of zeta-potential measurements in NanoEHS","volume":"3","author":"Lowry","year":"2016","journal-title":"Environ Sci: Nano"},{"key":"10.1016\/j.xphs.2025.104079_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28031498","article-title":"A review of different types of liposomes and their advancements as a form of gene therapy treatment for breast cancer","author":"Tseu","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.xphs.2025.104079_bib0041","doi-asserted-by":"crossref","DOI":"10.1080\/14686996.2019.1627174","article-title":"PEGylated liposomes: immunological responses","author":"Mohamed","year":"2019","journal-title":"Sci Technol Adv Mater"},{"key":"10.1016\/j.xphs.2025.104079_bib0042","article-title":"Chapter 6 - Nanoparticulate systems for therapeutic and diagnostic applications BT - emerging nanotechnologies for diagnostics, drug delivery and medical devices","author":"Kammari","year":"2017","journal-title":"In Micro Nano Technol"},{"issue":"3","key":"10.1016\/j.xphs.2025.104079_bib0043","doi-asserted-by":"crossref","DOI":"10.1007\/s12247-023-09732-7","article-title":"Development and characterization of soy lecithin liposome as potential drug carrier systems for doxorubicin","volume":"18","author":"Ahmed","year":"2023","journal-title":"J Pharm Innov"},{"key":"10.1016\/j.xphs.2025.104079_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/pr8091022","article-title":"Liposomes: from Bangham to supercritical fluids","author":"Trucillo","year":"2020","journal-title":"Processes"},{"key":"10.1016\/j.xphs.2025.104079_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.xphs.2025.104079_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/S0005-2736(01)00389-3","article-title":"On the mechanisms of internalization and intracellular delivery mediated by PH-sensitive liposomes","volume":"1515","author":"Sim\u00f5es","year":"2001","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"4","key":"10.1016\/j.xphs.2025.104079_bib0047","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.272.4.2382","article-title":"Sterically stabilized PH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo","volume":"272","author":"Slepushkin","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.xphs.2025.104079_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/S0065-2660(08)60152-2","article-title":"4 Pharmaceutical perspectives of nonviral gene therapy","volume":"41","author":"Mahato","year":"1999","journal-title":"In Adv Genet"},{"key":"10.1016\/j.xphs.2025.104079_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.623760","article-title":"Triggered drug release from liposomes: exploiting the outer and inner tumor environment","author":"Franco","year":"2021","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.xphs.2025.104079_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2021.183627","article-title":"Acidic PH-induced changes in lipid nanoparticle membrane packing","volume":"1863","author":"Koitabashi","year":"2021","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"2","key":"10.1016\/j.xphs.2025.104079_bib0051","doi-asserted-by":"crossref","DOI":"10.3109\/02656739509022457","article-title":"Extracellular ph distribution in Human tumours","volume":"11","author":"Engin","year":"1995","journal-title":"Int J Hyperth"},{"issue":"1","key":"10.1016\/j.xphs.2025.104079_bib0052","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98638-w","article-title":"Effects of hypoxia and nanocarrier size on PH-responsive nano-delivery system to solid tumors","volume":"11","author":"Soltani","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2025.104079_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/S1357-4310(99)01615-9","article-title":"Causes and consequences of tumour acidity and implications for treatment","author":"Stubbs","year":"2000","journal-title":"Mol Med Today"},{"issue":"7","key":"10.1016\/j.xphs.2025.104079_bib0054","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-015-1635-0","article-title":"Enhanced PH-responsiveness, cellular trafficking, cytotoxicity and long-circulation of PE gylated liposomes with post-insertion technique using gemcitabine as a model drug","volume":"32","author":"Xu","year":"2015","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.104079_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","author":"Hald Albertsen","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"issue":"SUPPL","key":"10.1016\/j.xphs.2025.104079_bib0056","article-title":"An investigation into some effective factors on encapsulation efficiency of alpha-tocopherol in MLVs and the release profile from the corresponding liposomal gel","volume":"12","author":"Tabandeh","year":"2013","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.xphs.2025.104079_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106267","article-title":"How docetaxel entrapment, vesicle size, zeta potential and stability change with liposome composition\u2013a formulation screening study","volume":"177","author":"Hols\u00e6ter","year":"2022","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104079_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/S0009-3084(02)00176-7","article-title":"The arrangement of cholesterol in membranes and binding of NAP-22","volume":"122","author":"Epand","year":"2003","journal-title":"In Chem Phys Lipids"},{"issue":"1","key":"10.1016\/j.xphs.2025.104079_bib0059","doi-asserted-by":"crossref","DOI":"10.1002\/pat.6235","article-title":"Development of peptide-18-targeted nanoliposome formulations with an alternative stealth coating copolymer for targeting breast cancer AU565 cell line","volume":"35","author":"Saka","year":"2024","journal-title":"Polym Adv Technol"},{"key":"10.1016\/j.xphs.2025.104079_bib0060","article-title":"Negatively charged liposomes of sertraline hydrochloride: formulation, characterization and pharmacokinetic studies","volume":"58","author":"Chauhan","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"10.1016\/j.xphs.2025.104079_bib0061","doi-asserted-by":"crossref","DOI":"10.1124\/pr.115.012070","article-title":"Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come","volume":"68","author":"Yingchoncharoen","year":"2016","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.xphs.2025.104079_bib0062","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/08982104.2024.2389969","article-title":"Effect of size and PH-sensitivity of liposomes on cellular uptake pathways and pharmacokinetics of encapsulated gemcitabine","volume":"35","author":"Tang","year":"2025","journal-title":"J Liposome Res"},{"issue":"9","key":"10.1016\/j.xphs.2025.104079_bib0063","doi-asserted-by":"crossref","DOI":"10.1039\/C6SC00221H","article-title":"Selective imaging and cancer cell death: via PH switchable near-infrared fluorescence and photothermal effects","volume":"7","author":"Zhang","year":"2016","journal-title":"Chem Sci"},{"key":"10.1016\/j.xphs.2025.104079_bib0064","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143526","article-title":"Cancer-associated fibroblasts: implications for Cancer therapy","author":"Maia","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.xphs.2025.104079_bib0065","doi-asserted-by":"crossref","DOI":"10.1080\/15384101.2016.1253641","article-title":"Cell proliferation downregulated by TGF-\u03922-triggered G1\/S checkpoint in clinical CAFs","volume":"16","author":"Wu","year":"2017","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.xphs.2025.104079_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2015.07.050","article-title":"A combination of Desmopressin and Docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (UPA) in Human prostate cancer cells","volume":"464","author":"Sasaki","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.xphs.2025.104079_bib0067","doi-asserted-by":"crossref","DOI":"10.34172\/bi.2023.23515","article-title":"Growth and invasion inhibition of T47D ductal carcinoma cells by the Association of Docetaxel with a bioactive agent in neutral nanosuspension","volume":"13","author":"Bawadud","year":"2023","journal-title":"BioImpacts"},{"key":"10.1016\/j.xphs.2025.104079_bib0068","doi-asserted-by":"crossref","DOI":"10.1186\/s12989-017-0199-z","article-title":"Mechanistic understanding of nanoparticles\u2019 Interactions with extracellular matrix: the cell and immune system","author":"Engin","year":"2017","journal-title":"Part Fibre Toxicol"},{"issue":"5","key":"10.1016\/j.xphs.2025.104079_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpj.2010.06.016","article-title":"Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions","volume":"99","author":"Stylianopoulos","year":"2010","journal-title":"Biophys J"},{"issue":"6","key":"10.1016\/j.xphs.2025.104079_bib0070","doi-asserted-by":"crossref","DOI":"10.4196\/kjpp.2016.20.6.595","article-title":"The P90rsk-mediated signaling of ethanol-induced cell proliferation in HepG2 cell line","volume":"20","author":"Kim","year":"2016","journal-title":"Korean J Physiol Pharmacol"},{"issue":"4","key":"10.1016\/j.xphs.2025.104079_bib0071","article-title":"Deactivation of cultured Human liver myofibroblasts by Trans- resveratrol, a grapevine-derived polyphenol","volume":"31","author":"Godihaud","year":"2000","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.xphs.2025.104079_bib0072","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201404715","article-title":"Peptide assembly integration of fibroblast-targeting and cell-penetration features for enhanced antitumor drug delivery","volume":"27","author":"Ji","year":"2015","journal-title":"Adv Mater"},{"issue":"17","key":"10.1016\/j.xphs.2025.104079_bib0073","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-10-0785","article-title":"Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness","volume":"70","author":"Giannoni","year":"2010","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.xphs.2025.104079_bib0074","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.31226","article-title":"Secreted factors from metastatic prostate cancer cells stimulate mesenchymal stem cell transition to a pro-tumourigenic \u2018activated\u2019 State that enhances prostate cancer cell migration","volume":"142","author":"Ridge","year":"2018","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.xphs.2025.104079_bib0075","doi-asserted-by":"crossref","DOI":"10.1620\/tjem.220.319","article-title":"Transforming growth factor-\u03b2 upregulates the expression of integrin and related proteins in MRC-5 Human myofibroblasts","volume":"220","author":"Honda","year":"2010","journal-title":"Tohoku J Exp Med"},{"issue":"5254","key":"10.1016\/j.xphs.2025.104079_bib0076","doi-asserted-by":"crossref","DOI":"10.1038\/227168a0","article-title":"Characteristics of a human diploid cell designated MRC-5","volume":"227","author":"Jacobs","year":"1970","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.xphs.2025.104079_bib0077","article-title":"Dynamic phenotypic reprogramming and chemoresistance induced by lung fibroblasts in small cell lung cancer","volume":"14","author":"Lu","year":"2024","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.xphs.2025.104079_bib0078","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.3390\/ijms25115691","article-title":"Ovarian cancer cell-conditioning medium induces cancer-associated fibroblast phenoconversion through glucose-dependent inhibition of autophagy","volume":"25","author":"Ferraresi","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.xphs.2025.104079_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2015.11.052","article-title":"Cdc42EP3\/BORG2 and Septin network enables mechano-transduction and the emergence of cancer-associated fibroblasts","volume":"13","author":"Calvo","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.xphs.2025.104079_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113757","article-title":"YAP, a novel target regulates F-Actin rearrangement-associated CAFs transformation and promotes colorectal cancer cell progression","volume":"155","author":"Naktubtim","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.xphs.2025.104079_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2018.02.011","article-title":"Resveratrol suppresses migration, invasion and stemness of Human breast cancer cells by interfering with tumor-stromal cross-talk","volume":"643","author":"Suh","year":"2018","journal-title":"Arch Biochem Biophys"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925005337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925005337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:37:42Z","timestamp":1771393062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925005337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0022354925005337"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104079","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combinatorial therapeutic effect of liposomes in inhibiting prostate cancer aggressiveness and targeting cancer-associated fibroblast","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}],"article-number":"104079"}}